Nathalie Nguyen
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 17 | 2025 | 325 | 5.780 |
Why?
| | Endoscopy, Digestive System | 7 | 2025 | 136 | 1.800 |
Why?
| | Esophagoscopy | 6 | 2025 | 209 | 1.750 |
Why?
| | Endoscopy, Gastrointestinal | 4 | 2024 | 227 | 1.730 |
Why?
| | Esophagitis | 3 | 2018 | 67 | 1.590 |
Why?
| | Gastritis | 3 | 2024 | 108 | 1.450 |
Why?
| | Esophagus | 7 | 2024 | 255 | 1.390 |
Why?
| | Eosinophilia | 5 | 2024 | 218 | 1.370 |
Why?
| | Postoperative Complications | 2 | 2025 | 2624 | 0.830 |
Why?
| | Dermatologic Agents | 1 | 2023 | 69 | 0.800 |
Why?
| | Sex Chromosomes | 1 | 2021 | 53 | 0.730 |
Why?
| | Virtual Reality | 2 | 2021 | 61 | 0.730 |
Why?
| | Aneuploidy | 1 | 2021 | 92 | 0.710 |
Why?
| | Enteritis | 2 | 2024 | 103 | 0.700 |
Why?
| | Child | 20 | 2025 | 21968 | 0.650 |
Why?
| | Intestine, Small | 2 | 2018 | 154 | 0.640 |
Why?
| | Genetic Association Studies | 1 | 2021 | 376 | 0.640 |
Why?
| | Patient Satisfaction | 1 | 2023 | 650 | 0.630 |
Why?
| | Gastroesophageal Reflux | 2 | 2018 | 234 | 0.620 |
Why?
| | Endoscopy | 1 | 2021 | 316 | 0.610 |
Why?
| | Eosinophil Peroxidase | 1 | 2018 | 7 | 0.610 |
Why?
| | Deglutition Disorders | 1 | 2020 | 143 | 0.600 |
Why?
| | Liver Transplantation | 1 | 2025 | 871 | 0.560 |
Why?
| | Child, Preschool | 13 | 2025 | 11069 | 0.560 |
Why?
| | Capsule Endoscopy | 1 | 2017 | 18 | 0.560 |
Why?
| | Mouth | 2 | 2023 | 86 | 0.410 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2417 | 0.400 |
Why?
| | Adolescent | 10 | 2025 | 21463 | 0.350 |
Why?
| | Retrospective Studies | 9 | 2025 | 15564 | 0.340 |
Why?
| | Foreign Bodies | 2 | 2023 | 104 | 0.330 |
Why?
| | Humans | 27 | 2025 | 136783 | 0.320 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 108 | 0.280 |
Why?
| | Prevalence | 2 | 2025 | 2712 | 0.260 |
Why?
| | Infant | 4 | 2025 | 9442 | 0.230 |
Why?
| | Young Adult | 6 | 2025 | 13126 | 0.220 |
Why?
| | Male | 13 | 2025 | 67361 | 0.220 |
Why?
| | Deglutition | 1 | 2024 | 72 | 0.210 |
Why?
| | Croup | 1 | 2023 | 26 | 0.200 |
Why?
| | Conscious Sedation | 1 | 2023 | 91 | 0.200 |
Why?
| | Esophageal Mucosa | 2 | 2024 | 22 | 0.200 |
Why?
| | Epithelial Cells | 2 | 2019 | 1093 | 0.200 |
Why?
| | Leukocyte Count | 2 | 2024 | 330 | 0.200 |
Why?
| | Female | 13 | 2025 | 72840 | 0.190 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 130 | 0.190 |
Why?
| | Glucocorticoids | 2 | 2024 | 596 | 0.190 |
Why?
| | Pregnenediones | 1 | 2021 | 19 | 0.180 |
Why?
| | Klinefelter Syndrome | 1 | 2021 | 61 | 0.170 |
Why?
| | Dilatation | 1 | 2020 | 65 | 0.170 |
Why?
| | Claudin-1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Claudins | 1 | 2019 | 25 | 0.160 |
Why?
| | Epithelium | 2 | 2019 | 311 | 0.150 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.150 |
Why?
| | Tight Junctions | 1 | 2019 | 77 | 0.150 |
Why?
| | Magnets | 1 | 2018 | 19 | 0.150 |
Why?
| | Genetic Testing | 1 | 2021 | 452 | 0.150 |
Why?
| | GATA3 Transcription Factor | 1 | 2018 | 26 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2023 | 804 | 0.140 |
Why?
| | Histocytochemistry | 1 | 2017 | 79 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 277 | 0.140 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1483 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 209 | 0.130 |
Why?
| | Adult | 6 | 2024 | 37616 | 0.130 |
Why?
| | Gastrostomy | 1 | 2018 | 112 | 0.130 |
Why?
| | Steroids | 1 | 2017 | 167 | 0.120 |
Why?
| | Biopsy | 1 | 2019 | 1126 | 0.120 |
Why?
| | Omeprazole | 1 | 2014 | 7 | 0.110 |
Why?
| | Disease Management | 1 | 2019 | 623 | 0.110 |
Why?
| | Chemokines, CC | 1 | 2014 | 33 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5417 | 0.110 |
Why?
| | Eosinophils | 3 | 2024 | 331 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2021 | 1036 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2018 | 538 | 0.100 |
Why?
| | Prospective Studies | 1 | 2025 | 7583 | 0.100 |
Why?
| | Fibroblasts | 1 | 2016 | 989 | 0.090 |
Why?
| | Asthma | 1 | 2023 | 2290 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2023 | 10764 | 0.070 |
Why?
| | Time Factors | 1 | 2019 | 6792 | 0.070 |
Why?
| | Signal Transduction | 1 | 2019 | 5065 | 0.060 |
Why?
| | Ultrasonography, Interventional | 1 | 2023 | 142 | 0.050 |
Why?
| | Endosonography | 1 | 2023 | 156 | 0.050 |
Why?
| | Cough | 1 | 2023 | 121 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 551 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2019 | 145 | 0.040 |
Why?
| | Protein Stability | 1 | 2019 | 177 | 0.040 |
Why?
| | Th2 Cells | 1 | 2018 | 176 | 0.030 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 193 | 0.030 |
Why?
| | Chemokine CCL26 | 1 | 2014 | 10 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2019 | 2162 | 0.030 |
Why?
| | Interleukin-13 | 1 | 2014 | 149 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1273 | 0.030 |
Why?
| | Down-Regulation | 1 | 2014 | 657 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2014 | 495 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3537 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2603 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2831 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4194 | 0.020 |
Why?
| | Middle Aged | 1 | 2024 | 33200 | 0.010 |
Why?
| | Mice | 1 | 2019 | 17731 | 0.010 |
Why?
| | Animals | 1 | 2019 | 36768 | 0.010 |
Why?
|
|
Nguyen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|